Document Detail


Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
MedLine Citation:
PMID:  17845538     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Evaluate the incidence of mental disorders using pegylated interferon plus ribavirin retreatment in nonresponder hepatitis C virus-infected patients. METHOD: The Mini-International Neuropsychiatric Interview (MINI) was used to evaluate 30 hepatitis C virus-infected interferon-nonresponder patients at baseline and following 4, 12 and 24 weeks of pegylated interferon retreatment. RESULTS: During the pegylated interferon/ribavirin retreatment, 5(16.6%) patients developed psychiatric side effects: 3(10%) were diagnosed with major depressive disorder, 1(3.3%) had a brief psychotic disorder and 1(3.3%) presented with panic attacks. CONCLUSION: This is the first prospective study evaluating the incidence of neuropsychiatric side effects during interferon retreatment of hepatitis C virus-infected patients, suggesting that the risk of acquiring serious psychiatric symptoms during retreatment with interferon-alpha (IFN-alpha) may not be higher than during the first antiviral therapy. This finding challenges the hypothesis that during a second treatment with IFN-alpha, patients with hepatitis C may be at greater risk for neuropsychiatric side effects than naïve patients.
Authors:
Lucas C Quarantini; Rodrigo A Bressan; Amanda Galvão; Susana Batista-Neves; Raymundo Paraná; Angela Miranda-Scippa
Related Documents :
2578268 - Persisting illness and fatigue in adults with evidence of epstein-barr virus infection.
8259188 - Treatment of chronic hepatitis d with interferon alfa-2a.
16611278 - 48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon ...
12120178 - Pegylated interferons.
22576468 - Barriers to hiv treatment among people who use injection drugs: implications for 'treat...
8634678 - Diagnosis of bacterial meningitis and septicemia by serum counterimmunoelectrophoresis.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Liver international : official journal of the International Association for the Study of the Liver     Volume:  27     ISSN:  1478-3223     ISO Abbreviation:  Liver Int.     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-11     Completed Date:  2007-12-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160857     Medline TA:  Liver Int     Country:  England    
Other Details:
Languages:  eng     Pagination:  1098-102     Citation Subset:  IM    
Affiliation:
University Hospital, Federal University of Bahia School of Medicine, Salvador-Bahia, Brazil. lcq@ufba.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Anxiety Agents / therapeutic use
Antidepressive Agents / therapeutic use
Antipsychotic Agents / therapeutic use
Antiviral Agents / adverse effects*
Depressive Disorder, Major / chemically induced*,  drug therapy,  epidemiology
Drug Therapy, Combination
Female
Hepatitis C / drug therapy*
Humans
Incidence
Interferon Alfa-2a / adverse effects*
Interferon Alfa-2b / adverse effects*
Male
Middle Aged
Panic Disorder / chemically induced*,  drug therapy,  epidemiology
Polyethylene Glycols / adverse effects*
Prospective Studies
Psychiatric Status Rating Scales
Psychotic Disorders / drug therapy,  epidemiology,  etiology*
Ribavirin / adverse effects*
Risk Assessment
Risk Factors
Time Factors
Treatment Failure
Chemical
Reg. No./Substance:
0/Anti-Anxiety Agents; 0/Antidepressive Agents; 0/Antipsychotic Agents; 0/Antiviral Agents; 0/Polyethylene Glycols; 0/peginterferon alfa-2a; 0/peginterferon alfa-2b; 36791-04-5/Ribavirin; 76543-88-9/Interferon Alfa-2a; 99210-65-8/Interferon Alfa-2b

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
Next Document:  Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and res...